KW-3902 in Patients With Acute Decompensated Heart Failure - KW-3902 in Patients With Acute Decompensated Heart Failure

Description:

The goal of the trial was to evaluate the effects of KW-3902 (rolofylline), an adenosine A1-receptor antagonist, on diuresis and renal function compared with placebo in patients with acute decompensated heart failure (ADHF).